Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $19.30M | $14.88M | $42.97M | $12.22M | $10.57M |
| Selling and Admin Expenses | $3.33M | $3.70M | $9.25M | $2.28M | $2.12M |
| -General & Admin Expense | $3.33M | $3.70M | $9.25M | $2.28M | $2.12M |
| Research & Development | $15.96M | $11.18M | $33.72M | $9.94M | $8.45M |
| Operating Profit | -$19.30M | -$14.88M | -$42.97M | -$12.22M | -$10.57M |
| Net Non-Operating Interest Income (Expense) | $2.05M | $1.78M | $2.51M | $603,000.00 | $738,000.00 |
| Non-Operating Interest Income | $2.05M | $1.78M | $2.51M | $603,000.00 | $738,000.00 |
| Other Income (Expense) | -$709,000.00 | -$599,000.00 | $25.18M | -$707,000.00 | -$323,000.00 |
| Earnings from Equity Interest | -$709,000.00 | -$599,000.00 | -$1.96M | -$707,000.00 | -$323,000.00 |
| Pretax Profit | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| Net Profit | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| Profit from Continuing Operations | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| Net Income to Parent Company | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| Net Income to Common Stockholders | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| Basic EPS | -$0.19 | -$0.15 | -$0.19 | -$0.15 | -$0.12 |
| Diluted EPS | -$0.19 | -$0.15 | -$0.53 | -$0.15 | -$0.12 |
| Gain on Sale of Security | – | – | $27.14M | $0.00 | – |
| Special Income (Charges) | – | – | $0.00 | – | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | $0.00 | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $239.27M | $253.20M | $71.12M | $71.12M | $80.47M |
| Total Current Assets | $220.97M | $239.95M | $58.21M | $58.21M | $66.94M |
| Cash and Cash Equivalents & Short-Term Investments | $215.23M | $236.71M | $56.75M | $56.75M | $65.69M |
| -Cash and Cash Equivalents | $18.91M | $40.10M | $4.58M | $4.58M | $2.87M |
| -Short Term Investments | $196.32M | $196.61M | $52.17M | $52.17M | $62.82M |
| Receivables | $1.85M | $1.20M | $374,000.00 | $374,000.00 | $346,000.00 |
| -Accounts Receivable | $6,000.00 | $43,000.00 | $37,000.00 | $37,000.00 | $32,000.00 |
| -Accrued Interest Receivable | $1.84M | $1.16M | $337,000.00 | $337,000.00 | $314,000.00 |
| Prepaid Assets | $3.31M | $1.67M | $772,000.00 | $772,000.00 | $400,000.00 |
| Other Current Assets | $575,000.00 | $367,000.00 | $318,000.00 | $318,000.00 | $509,000.00 |
| Total Non-Current Assets | $18.31M | $13.25M | $12.91M | $12.91M | $13.53M |
| Net PPE | $1.49M | $1.03M | $1.06M | $1.06M | $1.15M |
| -Gross PPE | $4.20M | $3.71M | $3.71M | $3.71M | $3.77M |
| -Accumulated Depreciation | -$2.71M | -$2.68M | -$2.65M | -$2.65M | -$2.62M |
| Investments and Advances | $15.11M | $10.50M | $10.99M | $10.99M | $11.53M |
| -Long Term Equity Investment | $15.11M | $10.50M | $10.99M | $10.99M | $11.53M |
| Other Non-Current Assets | $1.71M | $1.72M | $855,000.00 | $855,000.00 | $852,000.00 |
| Total Liabilities | $13.95M | $12.52M | $9.91M | $9.91M | $8.71M |
| Total Current Liabilities | $13.67M | $12.11M | $9.38M | $9.38M | $8.07M |
| Payables | $4.05M | $4.70M | $2.49M | $2.49M | $1.97M |
| -Accounts Payable | $4.05M | $4.70M | $2.49M | $2.49M | $1.97M |
| Current Accrued Expenses | $6.94M | $5.40M | $5.61M | $5.61M | $4.44M |
| Short-Term Debt and Capital Lease Obligation | $454,000.00 | $428,000.00 | $403,000.00 | $403,000.00 | $379,000.00 |
| -Current Capital Lease Obligation | $454,000.00 | $428,000.00 | $403,000.00 | $403,000.00 | $379,000.00 |
| Other Current Liabilities | $299,000.00 | $206,000.00 | $238,000.00 | $238,000.00 | $566,000.00 |
| Total Non-Current Liabilities | $274,000.00 | $406,000.00 | $534,000.00 | $534,000.00 | $632,000.00 |
| Long Term Debt and Capital Lease Obligation | $274,000.00 | $406,000.00 | $534,000.00 | $534,000.00 | $632,000.00 |
| -Long Term Capital Lease Obligation | $274,000.00 | $406,000.00 | $534,000.00 | $534,000.00 | $632,000.00 |
| Total Equity | $225.33M | $240.68M | $61.21M | $61.21M | $71.77M |
| Stockholders' Equity | $225.33M | $240.68M | $61.21M | $61.21M | $71.77M |
| Capital Stock | $8,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| -Common Stock | $8,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $670.56M | $667.78M | $474.39M | $474.39M | $472.79M |
| Retained Earnings | -$443.94M | -$425.99M | -$412.29M | -$412.29M | -$399.97M |
| Gains/Losses Not Affecting Retained Earnings | -$1.29M | -$1.13M | -$896,000.00 | -$896,000.00 | -$1.06M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$15.40M | -$10.37M | -$32.80M | -$9.19M | -$9.57M |
| Net cash flow from continuing operations | -$15.40M | -$10.37M | -$32.80M | -$9.19M | -$9.57M |
| Net Income from Continuing Operations | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| Gain/Loss from Continuing Operations | $709,000.00 | $599,000.00 | -$25.18M | $707,000.00 | $323,000.00 |
| Depreciation & Depletion & Amortization | $34,000.00 | $29,000.00 | $105,000.00 | $26,000.00 | $28,000.00 |
| Change in Working Capital | -$976,000.00 | $57,000.00 | $3.58M | $1.08M | -$550,000.00 |
| -Change in Receivables | $37,000.00 | -$6,000.00 | $38,000.00 | -$5,000.00 | $54,000.00 |
| -Change in Prepaid Assets | -$2.54M | -$1.76M | $941,000.00 | -$204,000.00 | $64,000.00 |
| -Change in Payables and Accrued Expense | $1.54M | $2.71M | $2.67M | $1.28M | -$455,000.00 |
| -Change in Other Current Assets | $99,000.00 | -$777,000.00 | $115,000.00 | $85,000.00 | -$141,000.00 |
| -Change in Other Current Liabilities | -$106,000.00 | -$103,000.00 | -$185,000.00 | -$74,000.00 | -$72,000.00 |
| Net cash flow from investing | -$5.97M | -$144.85M | -$7.80M | $10.88M | -$2.62M |
| Net Cash Flow from Continuing Investing Activities | -$5.97M | -$144.85M | -$7.80M | $10.88M | -$2.62M |
| Net PPE Purchase and Sale | -$582,000.00 | -$91,000.00 | -$174,000.00 | -$25,000.00 | $0.00 |
| Net Investment Purchase and Sale | -$383,000.00 | -$144.76M | -$7.62M | $10.91M | -$2.62M |
| Financing Cash Flow | $166,000.00 | $190.75M | $36.43M | $20,000.00 | $360,000.00 |
| Net Cash Flow from Continuing Financing Activities | $166,000.00 | $190.75M | $36.43M | $20,000.00 | $360,000.00 |
| Net Common Stock Issuance | $0.00 | $189.41M | $0.00 | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $166,000.00 | $1.34M | $36.43M | $20,000.00 | $360,000.00 |
| Ending Cash Balance | $18.91M | $40.10M | $4.58M | $4.58M | $2.87M |
| Net Change in Cash | -$21.20M | $35.53M | -$4.16M | $1.71M | -$11.82M |
| Beginning Cash Balance | $40.10M | $4.58M | $8.74M | $2.87M | $14.69M |
| Free Cash Flow | -$15.98M | -$10.47M | -$32.97M | -$9.22M | -$9.57M |
No comments yet — be the first to weigh in on CRVS.